Atherectomy and Thromboctomy Devices Market

The Atherectomy and Thromboctomy Devices Market size was valued at USD 4.17 Billion in 2025 and the total Atherectomy and Thromboctomy Devices revenue is expected to grow at a CAGR of 6.74% from 2025 to 2032, reaching nearly USD 6.59 Billion by 2032.

The report includes an analysis of the impact of COVID-19 lockdown on the revenue of market leaders, followers, and disruptors. Since the lockdown was implemented differently in various regions and countries; the impact of the same is also seen differently by regions and segments. The report has covered the current short-term and long-term impact on the market, and it would help the decision-makers to prepare the outline and strategies for companies by region.
To know about the Research Methodology :- Request Free Sample Report

Atherectomy and Thromboctomy Devices Market Definition

Atherectomy device cut and remove atherosclerotic plaque from a vessel wall or grind the atheroma into small particles, allowing them to embolize distally. Several types of atherectomy devices have been cleared by the U.S. Food and Drug Administration for peripheral use and primary success rates have been favorable with various devices.

The report covers the current estimated and forecasted data for the Global Atherectomy and Thromboctomy Devices Market on a global and regional level. The report provides an in-depth analysis of the Global Atherectomy and Thromboctomy Devices Market for the period 2025 – 2032, wherein 2025 is the base year and the period from 2025 to 2032 is the forecast period.

Data for 2016- 2018 has been included as historical information. The study provides a detailed perspective on market growth, throughout the above forecast period in terms of revenue estimates (in US$ Bn), across different geographies, which includes North America (NA), Europe (EU), Asia Pacific (APAC), Middle East & Africa (MEA) and Latin America (LATAM).

The Global Atherectomy and Thromboctomy Devices Market is segmented By Product, By End User and Region. The report provides qualitative and quantitative insights on the atherectomy and Thromboctomy devices industry trends and a detailed analysis of the market size and growth rate of all segments in the market.

Atherectomy and Thromboctomy Devices Market Dynamics

Technological advancement, increasing demand for minimally invasive devices and rising prevalence of chronic conditions are the driving factors for the global atherectomy and thromboctomy devices market. Growing patients with both lower and upper extremities artery diseases make a positive impact on the global market.

The SilverHawk and TurboHawk plaque excision systems are the two US Food and Drug Administration-approved directional atherectomy devices in use today. These devices have high demand in North America and the Asia Pacific.

Atherectomy and Thromboctomy Devices Market Segment Analysis – By Product

A number of percutaneous mechanical thrombectomy devices are currently being used or undergoing clinical evaluation for the treatment of acute and chronic limb-threatening ischemia. Efficacy and positive feedback of the rotational devices increase their demand globally. The growing applications of atherectomy and thromboctomy devices in complex patients cases and is driving the segment in the global market.

Atherectomy and Thromboctomy Devices Market Segment Analysis – By End User

The applications of atherectomy devices in the treatment of both coronary and peripheral arterial diseases increase the demand in hospitals. The higher success rate of cardiac & peripheral vascular disease treatment, ongoing technological advancements in the field of minimally invasive or image-guided atherectomy procedures, are expected to propel the global market in the forecast period.

The Asia Pacific is the dominant region in the global atherectomy and thromboctomy devices market in 2025 & is expected to maintain its position in the forecast period.

The high demand for Rotarex S rotational atherectomy system from the U.S, Europe gives the opportunity for prominent players to increase the production and product portfolio in the same regions. Mergers and acquisitions among the key players lead to increase the sale and revenue of them. Cardiovascular disease is the leading cause of mortality in North America. Nearly 17.9 million annual global deaths are surging the demand for thromboctomy devices for individuals who may be at risk of a cardiac event.

The objective of the report is to present a comprehensive analysis of the global atherectomy and thromboctomy devices market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.

The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding the global atherectomy and thromboctomy devices market dynamics, structure by analyzing the market segments and project the global atherectomy and thromboctomy devices market clear representation of competitive analysis of key players by price, financial position, by detection and equipment portfolio, growth strategies, and regional presence in the global atherectomy and thromboctomy devices market make the report investor’s guide.

Atherectomy and Thromboctomy Devices Market Key Highlights:

• Global Atherectomy and Thromboctomy Devices Market analysis and forecast, in terms of value.

• Comprehensive study and analysis of market drivers, restraints and opportunities influencing the growth of the Global Atherectomy and Thromboctomy Devices Market

• Global Atherectomy and Thromboctomy Devices Market segmentation on the basis of type, source, end-user, and region (country-wise) has been provided.

• Global Market strategic analysis with respect to individual growth trends, future prospects along with the contribution of various sub-market stakeholders have been considered under the scope of study.

• Global Market analysis and forecast for five major regions namely North America, Europe, Asia Pacific, the Middle East & Africa (MEA) and Latin America along with country-wise segmentation.

• Profiles of key industry players, their strategic perspective, market positioning and analysis of core competencies are further profiled.

• Competitive developments, investments, strategic expansion and competitive landscape of the key players operating in the Global Market are also profiled.

Atherectomy and Thromboctomy Devices Market Report Scope: Inquire before buying

Atherectomy and Thromboctomy Devices Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Atherectomy and Thromboctomy Devices Market, Key Players are:

1. Covidien PLC
2. Boston Scientific Corp.
3. Spectranetics Corp.
4. Bayer AG
5. Cardiovascular Systems Inc.
6. Argon Medical Devices
7. Spectranetics Corp.
8. Getinge AB
9. Straub Medical AG
10. Vascular Solutions Inc.
11. Zoll Medical Corp.
12. Terumo Medical Corp.
13. Uscom Ltd.
14. St. Jude Medical Inc.
15. Sorin Group USA Inc.
16. Ventracor Ltd
17. Medtronic plc
18. Koninklijke Philips N.V.
19. Abbott
20. Straub Medical AG
21. Avinger, Inc.
22. Philips
23. BIOTRONIK
24. C.R. Bard

Frequently Asked Questions:

1. Which region has the largest share in Global Market?
Ans: Asia Pacific region held the highest share in 2025.

2. What is the growth rate of Global Market?
Ans: The Global Market is growing at a CAGR of 6.74% during forecasting period 2026-2032.

3. What is scope of the Global Market report?
Ans: Global Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Market?
Ans: The important key players in the Global Market are – Covidien PLC, Boston Scientific Corp., Spectranetics Corp., Bayer AG, Cardiovascular Systems Inc., Argon Medical Devices, Spectranetics Corp., Getinge AB, Straub Medical AG, Vascular Solutions Inc., Zoll Medical Corp., Terumo Medical Corp., Uscom Ltd., St. Jude Medical Inc., Sorin Group USA Inc., Ventracor Ltd, Medtronic plc, Koninklijke Philips N.V., Abbott, Straub Medical AG, Avinger, Inc., Philips, BIOTRONIK, C.R. Bard, and

5. What is the study period of this Market?
Ans: The Global Market is studied from 2025 to 2032.